| Detection of mycobacterial RD antigens by nanoparticle based Immuno-PCR for the diagnosis of pulmonary and extrapulmonary tuberculosis | | 2015 | 2018 |
| Development of 1-[(2methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3ylidene] amino] thiourea (MBZM-N-IBT) as specific inhibitor of Chikungunya virus | | 2017 | 2020 |
| Development of biocompatible surfaces for ESKAPE pathogens | | 2017 | 2020 |
| Development of diagnostics and therapeutics for management of tuberculosis | | 2018 | 2021 |
| Diagnosis of neonatal bacterial meningitis by 16S rRNA genebased universal primer polymerase chain reaction and procalcitonin assay of cerebrospinal fluid | | 2016 | 2019 |
| Diagnostic markers for ocular tuberculosis | | 2018 | 2021 |
| Establishment of advanced technology platform centre for biotech science cluster, Faridabad | | 2011 | 2020 |
| Evaluation of a rapid Point-ofcare serodiagnostic test kit for the early diagnosis and prediction of drug resistant TB | | 2017 | 2018 |
| Evaluation of different rapid molecular methods for the diagnosis of mycobacterial infections (M.tuberculosis &NTM) and to study the various mechanisms of drug resistance due to Mycobacterium tuberculosis in patients of suspected tuberculous meningitis | | 2017 | 2020 |
| Evaluation of Loop Mediated Isothermal Amplification Assay (LAMP) for rapid detection of Mycobacterium tuberculosis from clinical samples | | 2018 | 2019 |